Home/CytoImmune Therapeutics/Jose Vidal, Ph.D.

JV

Jose Vidal, Ph.D.

Chief Operating Officer

CytoImmune Therapeutics

Therapeutic Areas

CytoImmune Therapeutics Pipeline

Drug	Indication	Phase
CAR-NK Cell Therapy	Solid Tumors and Hematologic Malignancies	Phase 1
CAR-NK Cell Therapy Platform	Oncology	Preclinical/Clinical Development

Leadership Team at CytoImmune Therapeutics

Michael A. Caligiuri, M.D.

Co-Founder & Chief Scientific Officer

View full CytoImmune Therapeutics profile